By activating GLP-1 receptors, retatrutide enhances insulin secretion in a glucose-dependent manner, suppresses glucagon release, and reduces appetite by acting on satiety centres in the brain
This multi-receptor activation differentiates retatrutide from monotherapy and dual-agonist compounds, positioning it as a significant research tool for investigating metabolic disorders
These products are not medicines or drugs, have not been evaluated or approved by the U.S
The result is policy by perception where stigma shapes law more than evidence does
The authors found that semaglutide, the active ingredient in the drugs Ozempic for diabetes and Wegovy for weight loss, as well as liraglutide (Saxenda) were associated with a lower risk of worsening mental illness in those with anxiety and depression
Pharmacy discount programs Pharmacy discount cards from services like GoodRx and SingleCare can provide savings of 1080% on GLP-1 medications, depending on the drug, dose, and pharmacy